← All companies

CORT

Corcept Therapeutics Incorporated

CORT Nasdaq Pharmaceutical Preparations EDGAR ↗

$112.80

-1.69 -1.48%

Key statistics

from XBRL data in SEC filings

Market cap

$12.2B

Revenue (TTM)

$831M

Net income (TTM)

$55.2M

EPS (TTM)

$0.42

P/E ratio

268.6

Dividend yield

—

Free cash flow

$142M

Cash

$111M

Total assets

$889M

Gross margin

41.9%

52-week range

$28.66 – $122.21

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 29, 2026 8-K Other events Jun 17, 2026 8-K Other events Jun 3, 2026 8-K Director or officer change; Shareholder vote results May 28, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2026 8-K Other events Mar 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 24, 2026 8-K Other events Feb 19, 2026 8-K Other events Jan 22, 2026 8-K Other events Dec 31, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 8-K Terminated a material agreement Oct 14, 2025 8-K Director or officer change Oct 6, 2025 8-K Other events Sep 10, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jul 31, 2025 8-K Other events Jul 14, 2025 8-K Shareholder vote results Jun 16, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 5, 2025 8-K Other events Mar 31, 2025 8-K Other events Mar 3, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2025 8-K Other events Dec 30, 2024 10-Q Quarter ended 2024-09-30 Oct 30, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 30, 2024 10-Q Quarter ended 2024-06-30 Jul 29, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jul 29, 2024 8-K Director or officer change; Shareholder vote results May 23, 2024 10-Q Quarter ended 2024-03-31 May 1, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 1, 2024 8-K Entered a material agreement; Took on a direct financial obligation Apr 17, 2024 10-K Fiscal year ended 2023-12-31 Feb 15, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 15, 2024 8-K Results of operations (earnings release); Other events Jan 8, 2024